Halia Therapeutics is a preclinical-stage biopharmaceutical company manufacturing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. Halia Therapeutics does this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate thedamage caused by aberrantly activated immune responses. Halia Therapeutics takes a novel approach to drug discovery by translating advances in understanding of the role of inflammation in human pathologies such as cancer and neurodegenerative diseases.

Biotechnology

Health Care

Pharmaceutical

Halia Therapeutics, Inc.

David Bearss Ph.D.

Margit (Maggie) Janát-Amsbury

Jeff Burton

Jared Bearss

Alexis Mollard, PhD

Leadership Team

Clinical and Operations Team

Teams at Halia Therapeutics, Inc.

Leadership Team

Clinical and Operations Team